Virulence of Escherichia coli Clinical Isolates in a Murine Sepsis Model in Relation to Sequence Type ST131 Status, Fluoroquinolone Resistance, and Virulence Genotype
Authors:
- 1 April 2012
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 80 (4) , 1554-1562
Abstract
Escherichia coli sequence type ST131 (O25b:H4) has emerged over the past decade as a globally disseminated, multidrug-resistant pathogen. Unlike traditional antimicrobial-resistant E. coli , ST131 derives from virulence-associated phylogenetic group B2 and exhibits extraintestinal virulence factors. This, plus preliminary evidence of virulence in experimental animals, has suggested that ST131's epidemic emergence may be due to high virulence potential, compared with other E. coli types. To test this hypothesis, we compared a large number of matched ST131 and non-ST131 E. coli clinical isolates, both fluoroquinolone resistant and susceptible, plus isolates from classic extraintestinal pathogenic E. coli (ExPEC) sequence types (STs) and case report ST131 household transmission isolates, for virulence in a mouse subcutaneous sepsis model. Overall, in mice, the study isolates produced a wide range of lethality and clinical illness. However, neither ST131 status nor fluoroquinolone phenotype correlated with this diversity of illness severity, which occurred within each of the 6 study groups. In contrast, multiple known or suspected ExPEC virulence genes, including pap (P fimbriae), vat (vacuolating toxin), kpsM II (group 2 capsule), ibeA (invasion of brain endothelium), and clbB/N (colibactin synthesis), plus molecularly defined ExPEC status, were significantly associated with virulence. These findings point away from ST131 isolates as having higher virulence potential compared with other E. coli types in causing invasive extraintestinal infections and suggest instead that ST131's epidemiological success may reflect enhanced fitness for upstream steps in pathogenesis or in colonization and transmission. Additionally, the extensive within-ST virulence diversity suggests an opportunity to compare closely related strains to identify the responsible genetic determinants.Keywords
This publication has 47 references indexed in Scilit:
- Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genesNature Genetics, 2011
- Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strainJournal of Antimicrobial Chemotherapy, 2010
- Escherichia coli Sequence Type ST131 as an Emerging Fluoroquinolone-Resistant Uropathogen among Renal Transplant RecipientsAntimicrobial Agents and Chemotherapy, 2010
- Transmission of an Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli (Sequence Type ST131) Strain between a Father and Daughter Resulting in Septic Shock and Emphysematous PyelonephritisJournal of Clinical Microbiology, 2009
- Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004Antimicrobial Agents and Chemotherapy, 2009
- Three-Decade Epidemiological Analysis of Escherichia coli O15:K52:H1Journal of Clinical Microbiology, 2009
- The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroupJournal of Antimicrobial Chemotherapy, 2008
- Virulence Genotypes and Phylogenetic Background ofEscherichia coliSerogroup O6 Isolates from Humans, Dogs, and CatsJournal of Clinical Microbiology, 2008
- Differential Stability and Trade-Off Effects of Pathoadaptive Mutations in the Escherichia coli FimH AdhesinInfection and Immunity, 2007
- The Complete Genome Sequence of Escherichia coli K-12Science, 1997